Product Overview
| Product |
Indication |
Phase of Development |
Territory |
| Litak® (Cladribine) |
hairy cell leukaemia or recurrent or refractory follicular and diffuse non-Hodgkin's lymphoma, recurrent or refractory chronic lymphocytic leukemia and recurrent or refractory lymphoplasmacytic lymphoma (Waldenström's macroglobulinemia)1) |
marketed |
EU/ROW |
| Dacin® (Dacarbazine) |
metastatic malignant melanoma, morbus Hodgkin, sarcoma |
marketed |
Switzerland |
| Santuril® (Probenecid) |
hyperuricemia (gout) |
marketed |
Switzerland |
1) approved indications may vary in different countries
|
